Welcome to the ValueWiki Alnylam Pharmaceuticals, Inc. (ALNY) article! Register for free or click the "edit" link to contribute!

Alnylam Pharmaceuticals, Inc. (ALNY)

This summary section needs content! Click Here to begin writing.

Have a question about Alnylam Pharmaceuticals, Inc.? Ask it on the Message Board or Chat Room

Visit the Apple, Inc. page for an example of a complete article.

Today

Max

Funds w/ ALNY:	6
Rank:	346 / 351

Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.^[1] Be bold!

12/01/08 2:12 pm	It's Wait Until Next Year for These Drugmakers (at Motley Fool)
12/01/08 10:12 am	Can MicroRNA Reverse Heart Disease? (at Seeking Alpha)
12/01/08 8:12 am	Alnylam Pharmaceuticals Call scheduled for 8:30 am ET today (CCBN)
11/30/08 1:11 pm	Regulus Therapeutics, Alnylam Pharmaceuticals, and Collaborators Publish First Ever In Vivo Efficacy Data for a microRNA Therapeutic in a Disease Model (Business Wire)
11/30/08 1:11 pm	Gene "silencing" drug blocks heart disease in mice (at Reuters)
11/28/08 6:11 am	[$$] Biotech Mailbag: All About Alnylam (at RealMoney by TheStreet.com)
11/26/08 4:11 pm	Alnylam to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference (Business Wire)
11/22/08 7:11 am	Alnylam sees results for liver disease treatment (at bizjournals.com)
11/20/08 8:11 am	Alnylam Presents Pre-clinical Data from TTR Amyloidosis Development Program (Business Wire)
11/19/08 9:11 am	Outlook for Small Cap Biotechnology Companies Discussed in Wall Street Transcript Report (Wall Street Transcript)